---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-120176"
form_type: "8-K"
ticker: "VSEE"
cik: "0001864531"
company_name: "VSEE HEALTH, INC."
filed_at: "2024-11-18T23:59:59+00:00"
generated_at: "2026-05-29T23:14:10.928115+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# VSee Health Q3 revenue up 131% to $3.4M; net loss $51.8M on $55M goodwill impairment

## Summary
- Q3 2024 revenue $3.4M (up 131% YoY); 9-month revenue $6.6M (+51%).
- Net loss $51.8M in Q3 driven by $55M goodwill impairment; pro forma net loss $0.4M ($(0.02)/share).
- Cash $2.3M at Sept 30; no guidance provided.
- Pro forma 9-month net loss $(0.16)/share vs $(0.24)/share a year ago.
- Expanded partnerships with Seven Corners, SkywardRx, Ava Robotics; launched Aimee and GLP-1 telehealth program.

## SEC filing metadata
- accession: 0001104659-24-120176
- form_type: 8-K
- ticker: VSEE
- cik: 0001864531
- company_name: VSEE HEALTH, INC.
- filed_at: 2024-11-18T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1864531/000110465924120176/0001104659-24-120176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1864531/000110465924120176/tm2428698d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-120176
- JSON: https://secwatch.observer/filing/0001104659-24-120176.json
- Plain text: https://secwatch.observer/filing/0001104659-24-120176.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
